The Role of Biomarkers in Neuroendocrine Tumors

Matthew H. Kulke, MD, and panelists, Rodney F. Pommier, MD, and James C. Yao, MD, discuss the role of biomarkers in the screening and diagnosis of patients with neuroendocrine tumors.

For more from this discussion, visit http://www.onclive.com/peer-exchange/nets

• categorie